Dr. Taylor is leading international regenerative medicine research efforts, creating cutting edge therapies for chronic disease and “building the future treatments of tomorrow." An educator with over 25 years of teaching experience, she is truly committed to moving innovative therapies from bench to bedside, while preparing students/fellows to compete at an international level in the field of cardiac and vascular repair and regeneration.
Dr. Doris A. Taylor has worked in the field of cardiovascular regenerative medicine since its inception and is widely regarded as a major thought-leader in the field. Her mechanistic insights and effective approaches to cardiac repair and replacement are well established and include a number of firsts.
When on the Duke University faculty, 1991-2003, she described the first functional repair of injured heart with stem cells. As director of the Center for Cardiovascular Repair at the University of Minnesota, 2003-2012, she recognized that cell therapy is unlikely to reverse end-stage organ failure; her lab began working to build organs for transplant in the laboratory. Realizing cells were available but scaffold technology lagging, her group developed a unique method to remove cells from otherwise unusable organs, leaving an intact scaffold of extracellular matrix. In 2009, she founded Miromatrix Medical Inc. to commercialize the organ perfusion decellularization/recellularization technologies developed in her lab.
Arriving at Texas Heart Institute in 2012, Dr. Taylor established both the Department of Regenerative Medicine Research and the Center for Cell and Organ Biotechnology, the latter in partnership with the Texas A&M University College of Veterinary Medicine. She also heads the Cardiovascular Cell Therapy Research Network (CCTRN) Biorepository, the cell and cytokine profiling core lab that serves multiple NIH, National Heart Lung and Blood Institute (NHLBI) networks, medical centers, and research foundations in the U.S. and Canada. She holds faculty appointments at Texas A&M and Rice University and serves as a consultant for both academic and commercial enterprises in the regenerative medicine space. She recently founded and leads a new company, Stem Cell Security, LLC, a cell banking and data management company in Houston, Texas. She has published extensively, authoring or co-authoring more than 150 scientific publications and co-editing 2 textbooks.